Researcher

Dr Juliana de Oliveira Costa

My Expertise

I am recognised nationally and internationally as an emerging leader in pharmacoepidemiology using routinely collected data, such as administrative health data and electronic health records. My vision is to use these data to improve medicine use in populations, achieving better health outcomes and reducing medicine-related harm. The overall aim of my research is to increase health systems efficiency and the quality of life of people living with physical and mental health conditions. I have a strong focus on infectious diseases, mental health and cardiometabolic diseases, both for treatment and prevention of health events. My research investigates the patterns of use of medicines in the population, including, but not limited to, adherence of patients to therapy, prescriber’s behaviour, and inappropriate and wasteful use (such as the use of low-value services).

Keywords

Fields of Research (FoR)

Public Health and Health Services, Epidemiology, Clinical Pharmacology and Therapeutics

Biography

I am a research-focused level B working with large administrative data and electronic health records to improve the use of medicines in populations.

I am a pharmacist by training with a background in public health and health technology assessment. I am specialising in pharmacoepidemiology and health economics in the Medicines Intelligence Unit at the School of Population Health and my research interests include developing studies in the...view more

I am a research-focused level B working with large administrative data and electronic health records to improve the use of medicines in populations.

I am a pharmacist by training with a background in public health and health technology assessment. I am specialising in pharmacoepidemiology and health economics in the Medicines Intelligence Unit at the School of Population Health and my research interests include developing studies in the real-world setting. Some of my current and past projects include: examining the quality of care among people undergoing revascularisation procedures in NSW public hospitals, rates of low-value care services in NSW public hospitals, patterns of antidepressant use and trajectories of adherence to HIV regimens in Australia; performing comparative effectiveness studies between first-line regimens for HIV treatment; evaluating costs and benefits of HIV treatment, immunosuppressants for kidney transplantation, antipsychotics, and biological medicines for rheumatic diseases in the Brazilian context.  

 


My Grants

NHMRC Partnership Project (ID:2007402; $1,216,847) “Identifying the predictors and consequences of disparities in the uptake of HIV prevention and treatment programs in Australia: a national data linkage study” (Associate Investigator) 


My Qualifications

PhD (Public Health) - Federal University of Minas Gerais, 2019

MPH - Federal University of Minas Gerais, 2014

BPharm (Pharmacy) - Federal University of Minas Gerais, 2009


My Awards

2020, Best Paper by a PhD Candidate (Highly Commended) -  Health Services Research Association of Australian and New Zealand 

2020, Best PhD thesis - Postgraduate Program in Public Health, UFMG 

2020, AIDS 2020: Virtual Scholarship Programme - International AIDS Society 

2019, Spotlight Poster Winner - 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

2018, Endeavour Research Fellowship - Department of Education and Training, Australian Government

2018, Visiting Student Scholarship - CAPES Foundation


My Research Activities

My research has contributed substantially to improve the quality use of medicines and to inform policymaking. The quality of my work is recognised by publication in top quartile journals, presentations at international conferences, awards, scholarships, and co-supervision of an HDR student and over 300 citations.  I work collaboratively and contributed to creating new collaborations hubs across UNSW research centres, including the Kirby Institute and the Centre for Primary Health Care and Equity.


My Research Supervision


Supervision keywords


Areas of supervision

My area of specialty is pharmacoepidemiology and health technology assessment especially focused on medicines. I am interested in how medicines are used in populations and the consequences of their use in the real-world context – not just in clinical trials. I investigate the use and outcomes of medicines using mostly large administrative data and electronic health records, which are data routinely collected in our daily interactions with the health care system. My research helps to improve the quality use of medicines, providing the evidence needed to influence clinical guidelines and pharmaceutical policy.


Currently supervising

I have previously supervised to completion:

  • One PhD in Medicines and Pharmaceutical Policy (joint supervisor) 
  • Three Masters of Health Data Science students (primary and co-supervisor)
  • Two Honours / Independent Learning Project students (co-supervisor)

My Engagement

Membership

  • Health Services Research Association of Australia and New Zealand (2020 to date)
  • International AIDS Society (2020 to date)
  • ISPOR Student and ECR Chapter (2018 to date)
  • Brazilian Association of Public Health [Associação Brasileira de Saúde Coletiva – ABRASCO] – (2017 to date)

Peer review of manuscripts (See Publons for further details)

  • Frontiers in Pharmacoepidemiology (Jun 2020 to date) 
  • Journal of Comparative Effectiveness Research (Jan 2020 to date) 
  • Patient Related Outcomes Measures (Dec 2019 to date) 
  • Applied Research in Quality of Life (Oct 2019 to date) 
  • Revista de Psiquiatria Clínica (Oct 2019 to date) 
  • Frontiers in Public Health (Jun 2019 to date) 
  • Revista de Saúde Pública (Apr 2019 to date) 
  • International Journal of STD and AIDS (Mar 2019 to date) 
  • European Journal of Clinical Pharmacology (Jul 2018 to date) 
  • Ciência & Saúde Coletiva (Oct 2016 to date) 

Organising committee co-leader

  • Capacity Building and Training, Medicines Intelligence CRE (2021 to date)
  • CBDRH Research meetings (2020 to 2022)

Collaboration with external partners

  • NPS MedicineWise 
  • International researchers from Brazil (UFMG), Scotland (University of Strathclyde) and Canada (McGill University)

My Teaching

My teaching interests combine the areas of pharmacoepidemiology, public health and health economics to provide the population with medicines and other health interventions that are effective, safe and affordable.

I currently teach in HDAT9100 - Context of Health Data Science (Chapter instructor, 2020 - present). I previously taught Pharmacoepidemiology, Community Pharmacy and Professional Practice (UFMG).

View less